Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 45,450 shares at $45.05 ($2.0M) on 2025-08-27, disclosed to the SEC on 2025-08-29.
Scheduled sale ($2.0M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.05 | 10,650 | $480K | 23.4% |
| 2 | $45.05 | 10,650 | $480K | 23.4% |
| 3 | $45.12 | 24,150 | $1.1M | 53.2% |
| Total | $45.09 avg | 45,450 | $2.0M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |